SPRBD / Spruce Biosciences, Inc. - Net Long/Short Value

Spruce Biosciences, Inc.
US ˙ OTCPK ˙ US85209E1091
DIESES SYMBOL IST NICHT MEHR AKTIV

SPRBD / Spruce Biosciences, Inc. - Net Long/Short Value
Auf dieser Seite finden Sie die Netto-Long/Short-Bewertungen für jede institutionelle Beteiligung, die über die 13F- oder NPORT-Berichte gemeldet wurde. Um den Netto-Long/Short-Wert zu berechnen, addieren wir den Aktienwert zum Wert der Call-Option und ziehen den Wert der Put-Option ab. Fonds, die geliehene Short-Positionen melden, weisen den Aktienwert als negativ aus. Netto-Long-Positionen haben positive Zahlen in der Netto-Long/Short-Spalte, und Netto-Short-Positionen haben negative Werte in dieser Spalte.
Besitzer Eigenkapitalwert
($1000)
Call Wert
($1000)
Put Wert
($1000)
Net Long/Short
($1000)
Geode Capital Management, Llc
Morgan Stanley
Boothbay Fund Management, Llc
StemPoint Capital LP
Citigroup Inc
Squadron Capital Management LLC
Diadema Partners Lp
Millennium Management Llc
Vanguard Global Advisers, LLC
Balyasny Asset Management Llc
Sound Income Strategies, LLC
Persistent Asset Partners Ltd
Jones Financial Companies Lllp
ExodusPoint Capital Management, LP
Caldwell Securities, Inc
Goldman Sachs Group Inc
ADAR1 Capital Management, LLC
Resolute Capital Asset Partners LLC
UBS Group AG
Alyeska Investment Group, L.P.
Vanguard Capital Management Llc
BlackRock, Inc.
Wellington Management Group Llp
Citadel Advisors Llc
State Street Corp
Tower Research Capital LLC (TRC)
Vanguard Group Inc
Carlyle Group Inc.
Lion Point Capital, LP
Ikarian Capital, LLC
Cassaday & Co Wealth Management LLC
Vanguard Fiduciary Trust Co
Marex Group plc
Quinn Opportunity Partners LLC
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:SPRB 50,43 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista